Search Results
Found 6 results
510(k) Data Aggregation
(33 days)
Nitrile Examination Gloves Powder Free Tested for Use With Chemotherapy Drugs & Fentanyl Citrate (Blue
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.
Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powder-free class I Nitrile Patient Examination Gloves which coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs. The subject devices are identical in design and formulation to the predicate gloves of K230121.
The provided FDA 510(k) clearance letter pertains to Nitrile Examination Gloves Powder Free Tested for Use With Chemotherapy Drugs & Fentanyl Citrate (Blue & Black), a medical device. This type of device is classified as a Class I medical device and does not involve AI/ML technology. Therefore, many of the requested categories related to AI/ML device studies (e.g., sample sizes for test/training sets, ground truth establishment, MRMC studies, standalone performance, expert qualifications, adjudication methods, effect sizes) are not applicable.
The acceptance criteria and device performance are primarily evaluated based on material properties, chemical permeation resistance, and biocompatibility, using established ASTM and ISO standards for examination gloves.
1. Table of Acceptance Criteria and Reported Device Performance
The device, "NITRILE EXAMINATION GLOVES POWDER FREE TESTED FOR USE WITH CHEMOTHERAPY DRUGS & FENTANYL CITRATE (BLUE & BLACK)", was tested against various physical, chemical, and biological criteria.
Test Category | Characteristic / Standard | Acceptance Criteria | Reported Device Performance (Result) |
---|---|---|---|
Preamble | Product Code | LZA, LZC, QDO, OPJ | LZA, LZC, QDO, OPJ |
Intended Use | To prevent contamination between patient and examiner | Meets stated intended use | |
Design | Powder Free, Non-Sterile, Ambidextrous, Beaded Cuff | Powder Free, Non-Sterile, Ambidextrous, Beaded Cuff | |
Construction | Ambidextrous, Polymer Coated or Chlorinated, Powder Free Nitrile | Ambidextrous, Polymer Coated or Chlorinated, Powder Free Nitrile | |
Color Description | Blue & Black | Blue & Black | |
Material | Nitrile | Nitrile | |
Single Use | Yes | Yes | |
Packaging | Packed in Dispenser Boxes | Packed in Dispenser Boxes | |
Sterility | Non-Sterile | Non-Sterile | |
Freedom From Holes | ASTM D6319-19, ASTM D5151-19 | Meet requirement inspection level G-1, AQL 2.5 | Pass |
Dimension | ASTM D6319-19 | Length (XS), min. 220mm | Meet 220mm min |
Length (S, M, L, XL), min. 230mm | Meet 230mm min | ||
Thickness (palm/finger), min. 0.05mm | Meet 0.05mm min | ||
Width (XS), 70 ± 10 mm | Meet 70 ± 10 mm | ||
Width (S), 80 ± 10 mm | Meet 80 ± 10 mm | ||
Width (M), 95 ± 10 mm | Meet 95 ± 10 mm | ||
Width (L), 110 ± 10 mm | Meet 110 ± 10 mm | ||
Width (XL), 120 ± 10 mm | Meet 120 ± 10 mm | ||
Physical Properties (Before Ageing) | ASTM D6319-19 | Tensile Strength, 14 MPa min. | Meet 14MPa min. |
Ultimate Elongation, 500% min. | Meet 500% min. | ||
Physical Properties (After Accelerated Aging) | ASTM D6319-19 | Tensile Strength, 14 MPa min. | Meet 14MPa min. |
Ultimate Elongation, 400% min. | Meet 400% min. | ||
Residual Powder Content | ASTM D6319-19, ASTM D6124-06 | Not more than 2 mg per glove | Meet 2mg/glove max. |
Biocompatibility - Primary Skin Irritation | ISO 10993-10 | Not a primary skin irritant | Pass (did not cause an irritant response) |
Biocompatibility - Skin Sensitization | ISO 10993-10 | Not a contact sensitizer | Pass (did not produce a skin sensitization effect) |
Biocompatibility - In Vitro Cytotoxicity | ISO 10993-5:2009 | No adverse biological reaction | Moderate cytotoxicity reactivity at 6.0 cm²/mL extract concentrations and no cytotoxicity reactivity at 3.0 cm²/mL extract concentrations. |
Biocompatibility - Acute Systemic Toxicity | ISO 10993-11 | No adverse biological reaction | Pass (no adverse biological reaction) |
Chemotherapy Drug Permeation | ASTM D6978-05 (Reapproved 2019) | Varies by drug (Breakthrough Detection Time) | See detailed table below |
Detailed Chemotherapy Drug and Fentanyl Citrate Permeation Performance:
Chemotherapy Drugs and Fentanyl Citrate | Concentration | Minimum Breakthrough Detection Time (minutes) - Blue Glove | Minimum Breakthrough Detection Time (minutes) - Black Glove |
---|---|---|---|
*Carmustine (BCNU) | 3.3 mg/ml | 22.6 | 21.8 |
Cisplatin | 1.0 mg/ml | >240 min | >240 min |
Cyclophosphamide (Cytoxan) | 20.0 mg/ml | >240 min | >240 min |
Dacarbazine | 10.0 mg/ml | >240 min | >240 min |
Doxorubicin HCL | 2.0 mg/ml | >240 min | >240 min |
Etoposide | 20.0 mg/ml | >240 min | >240 min |
Fluorouracil | 50.0 mg/ml | >240 min | >240 min |
Ifosfamide | 50.0 mg/ml | >240 min | >240 min |
Mitoxantrone | 2 mg/ml | >240 min | >240 min |
Paclitaxel | 6.0 mg/ml | >240 min | >240 min |
*Thio Tepa | 10.0 mg/ml | 43.9 | 17.7 |
Vincristine Sulfate | 1.0 mg/ml | >240 min | >240 min |
Methotrexate | 25.0 mg/ml | >240 min | >240 min |
Mitomycin C. | 0.5 mg/ml | >240 min | >240 min |
Fentanyl Citrate | 100mcg/2ml | >240 min | >240 min |
*Warning: Do not use with Carmustine and Thiotepa due to extremely low permeation times. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the exact sample sizes for each test (e.g., number of gloves tested for permeation, holes, dimensions, etc.) but refers to adherence to the methodologies outlined in the specified ASTM and ISO standards. These standards typically define minimum sample sizes for material testing.
- Data Provenance: The document states the applicant is from Malaysia (Careglove Global Sdn. Bhd.). The testing was conducted according to international standards (ASTM, ISO), implying the tests were performed in a controlled laboratory environment, likely by the manufacturer or a contracted lab. The data is non-clinical and derived from prospective testing of manufactured glove samples.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. This device is not an AI/ML device that requires expert review for "ground truth" establishment in the context of diagnostic or interpretive tasks. The "ground truth" for material properties is established by the physical and chemical measurements themselves, according to standardized protocols and certified laboratory equipment.
4. Adjudication Method for the Test Set
Not applicable. This device is not an AI/ML device that requires adjudication for interpretations. Test results are objective measurements against predefined criteria.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
Not applicable. MRMC studies are relevant for diagnostic or interpretive AI/ML devices where human readers' performance is evaluated with and without AI assistance. This is a physical and chemical barrier device.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done
Not applicable. This device is a passive physical barrier and does not involve any algorithms or software.
7. The Type of Ground Truth Used
The "ground truth" for this device is based on objective measurements of physical properties (e.g., length, thickness, tensile strength, elongation), chemical resistance (breakthrough detection time), and biological reactivity (biocompatibility tests), as defined by internationally recognized standards (ASTM, ISO). There is no subjective human "ground truth" in this context.
8. The Sample Size for the Training Set
Not applicable. This is not an AI/ML device that undergoes "training."
9. How the Ground Truth for the Training Set Was Established
Not applicable. This is not an AI/ML device. The manufacturing process of the gloves is designed to meet the specified standards, and quality control ensures consistency, but this is not "training" in the context of AI/ML.
Ask a specific question about this device
(72 days)
Sterile Nitrile Examination Gloves Powder Free Tested for Use with Chemotherapy Drugs and Fentanyl Citrate
Ask a specific question about this device
(118 days)
Nitrile Examination Gloves Powder Free Tested For Use With Chemotherapy Drugs & Fentanyl Citrate (Blue
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.
Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powderfree variation of the class I Nitrile Patient Examination Gloves which is coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs and Fentanyl Citrate.
This document describes the testing for Nitrile Examination Gloves, focusing on their resistance to chemotherapy drugs and Fentanyl Citrate. The study assesses the gloves' physical properties, biocompatibility, and chemical permeation alongside the reported device performance.
1. Table of Acceptance Criteria and Reported Device Performance
Chemotherapy and Fentanyl Citrate Permeation (Minimum Breakthrough Detection Time)
Chemotherapy Drugs | Concentration | Acceptance Criteria (from ASTM D6978-05 implied by claim of use) | Reported Device Performance (Blue Glove) | Reported Device Performance (Black Glove) |
---|---|---|---|---|
Carmustine (BCNU) | 3.3 mg/ml | No specific public acceptance criterion provided but tested | 22.6 minutes | 21.8 minutes |
Cisplatin | 1.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Cyclophosphamide (Cytoxan) | 20.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Dacarbazine | 10.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Doxorubicin HCl | 2.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Etoposide | 20.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Fluorouracil | 50.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Ifosfamide | 50.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Mitoxantrone | 2 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Paclitaxel | 6.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Thiotepa | 10.0 mg/ml | No specific public acceptance criterion provided but tested | 43.9 minutes | 17.7 minutes |
Vincristine Sulfate | 1.0 mg/ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Fentanyl Citrate Injection | 100mcg/2ml | No specific public acceptance criterion provided but tested | >240 minutes | >240 minutes |
Warning | Advised against use if permeation time is too low | Carmustine, Thiotepa warning | Carmustine, Thiotepa warning |
Physical Properties, Dimensional, and Biocompatibility Testing
Test | Method | Acceptance Criteria | Reported Device Performance |
---|---|---|---|
Freedom From Holes | ASTM D6319-19, D5151-19 | Requirement inspection level G-1, AQL 2.5 | Pass |
Dimension (Length, Thickness, Width) | ASTM D6319-19 | Length: min. 220mm, 230mm. Thickness: min. 0.05mm. Width: 70-120mm (based on size) | Pass (Meets requirements for various sizes) |
Physical Properties (Before Aging) | ASTM D6319-19 | Tensile Strength: 14 MPa min. Ultimate Elongation: 500% min. | Pass (Meets 14MPa min, 500% min) |
Physical Properties (After Aging) | ASTM D6319-19 | Tensile Strength: 14 MPa min. Ultimate Elongation: 400% min. | Pass (Meets 14MPa min, 400% min) |
Residual Powder Content | ASTM D6319-19, D6124-06 | Not more than 2 mg per glove | Pass |
Primary Skin Irritation Test | ISO 10993-10 | Not a primary skin irritant | Pass (Did not cause an irritant response) |
Skin Sensitization Test | ISO 10993-10 | Not a contact sensitizer | Pass (Did not produce a skin sensitization effect) |
In Vitro Cytotoxicity Test | ISO 10993-5:2009 | No adverse biological reaction | Moderate cytotoxicity at 6.0 cm²/mL; No reactivity at 3.0 cm²/mL |
Acute Systemic Toxicity | ISO 10993-11 | No adverse biological reaction | Pass (No adverse biological reaction) |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the sample size (number of gloves) used for the permeation, physical property, or biocompatibility tests.
The data provenance is not explicitly mentioned (e.g., country of origin, retrospective or prospective). However, the tests were conducted according to international standards (e.g., ASTM, ISO), which implies a standardized, prospective testing approach in a laboratory setting. The applicant is based in Malaysia.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. This is not a study involving expert readers or ground truth established by medical professionals. The "ground truth" for this device is determined by objective, standardized laboratory measurements (e.g., chemical permeation time, physical properties, biological reactions) as defined by the referenced ASTM and ISO standards.
4. Adjudication Method for the Test Set
Not applicable. There was no human adjudication process involved as the "ground truth" is determined by objective laboratory measurements and adherence to specified test standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic devices that involve human interpretation of medical images or data. The device in question is examination gloves, and its performance is evaluated through physical, chemical, and biological testing, not by human readers interpreting cases.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
Not applicable. This is a medical device (examination gloves), not an AI algorithm. Therefore, the concept of "standalone" performance for an algorithm does not apply. All listed tests are "standalone" in the sense that they assess the intrinsic properties of the glove without human intervention in the measurement process itself, though human technicians conduct and analyze the tests.
7. The Type of Ground Truth Used
The ground truth used for this study is based on:
- Performance Standards: Defined by international standards such as ASTM D6978-05 (for chemotherapy drug permeation), ASTM D6319-19, ASTM D5151-19, ASTM D6124-06 (for physical properties and hole freedom), and ISO 10993-10, ISO 10993-5:2009, ISO 10993-11 (for biocompatibility).
- Objective Laboratory Measurements: Direct measurements of breakthrough time, dimensional properties, tensile strength, elongation, residual powder, and biological response to the glove materials.
8. The Sample Size for the Training Set
Not applicable. There is no training set mentioned or implied in this submission, as the device is not an AI/ML algorithm that requires training data.
9. How the Ground Truth for the Training Set was Established
Not applicable, as there is no training set for this device.
Ask a specific question about this device
(184 days)
Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl
Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate is a disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. Additionally, the gloves were tested for use with chemotherapy drugs and Fentanyl Citrate in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Medical Glove to Permeation by Chemotherapy Drugs.
The subject device in 510(K) notification is a blue nitrile examination gloves powder free tested for use with Chemotherapy drugs and Fentanyl Citrate. The subject device is a patient examination glove made from acrylonitrile-butadiene copolymer dispersion, blue color, powder free and non sterile (as per 21CFR 880.6250, class I). The device is available in Small, Medium, Large and Extra Large sizes. The subject device meets all the current specifications listed under the ASTM Specification D 6319 -2019, Standard Specification for Nitrile Examination Gloves for Medical Application. This device also complies with requirements for standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs as per ASTM D6978- 05(2019)
The provided document is a 510(k) premarket notification for "Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate." This document outlines the acceptance criteria and the results of a study to demonstrate the device's performance.
Here's the breakdown of the information requested based on the provided text:
1. A table of acceptance criteria and the reported device performance
The document provides extensive tables for the performance of the gloves. Rather than recreating the entire tables found on pages 10-14, a summary of key acceptance criteria and reported performance is presented below. Please refer to pages 10-14 of the original document for the complete lists of chemotherapy drugs and specific results.
Test Method (Standard) | Purpose | Acceptance Criteria | Reported Device Performance |
---|---|---|---|
ASTM D6319-2019 | Length of the gloves | Min 220 mm for Size Small & Min 230 mm for all other sizes | Small: 404 mm |
Medium: 405 mm | |||
Large: 405 mm | |||
X-Large: 406 mm (All exceed minimums) | |||
ASTM D6319-2019 | Width of the gloves | Small: 80+/-10 mm; Medium: 95+/-10 mm; Large: 110+/-10 mm; X-Large: 120+/-10 mm | Small: 84 mm |
Medium: 94 mm | |||
Large: 105 mm | |||
X-Large: 115 mm (All within +/- 10mm range) | |||
ASTM D6319-2019 | Thickness of the gloves | Palm 0.05 mm min; Finger 0.05 mm min for all sizes | Palm: 0.19mm (all sizes); Finger: 0.21mm (all sizes) (All exceed minimums) |
ASTM D6319-2019 | Physical properties - Tensile strength (Before Ageing) | $\ge$ 14 Mpa for all sizes | Small: 22.77Mpa; Medium: 24.46Mpa; Large: 24.51Mpa; X-Large: 24.59Mpa (All exceed minimum) |
ASTM D6319-2019 | Physical properties - Tensile strength (After Ageing) | $\ge$ 14 Mpa for all sizes | Small: 20.50Mpa; Medium: 21.81Mpa; Large: 21.95Mpa; X-Large: 22.05Mpa (All exceed minimum) |
ASTM D6319-2019 | Physical properties - Ultimate Elongation (Before Ageing) | $\ge$ 500% for all sizes | Small: 885%; Medium: 888%; Large: 891%; X-Large: 892% (All exceed minimum) |
ASTM D6319-2019 | Physical properties - Ultimate Elongation (After Ageing) | $\ge$ 400% for all sizes | Small: 868%; Medium: 870%; Large: 872%; X-Large: 875% (All exceed minimum) |
ASTM D5151-2019 | Detection of Holes in Medical Gloves | AQL 2.5 | Passes AQL 1.5 (Better than acceptance criteria, indicating fewer defects) |
ASTM D6124-06 | Residual Powder on Medical Gloves | 2 Mg/Glove Max | Small: 0.16 mg/glove; Medium: 0.16 mg/glove; Large: 0.16 mg/glove; X-Large: 0.16mg/glove (All meet or are below maximum) |
ASTM D6978-05 (2019) | Permeation by Chemotherapy Drugs and Fentanyl Citrate | Specified minimum breakthrough detection times for each drug (e.g., >240 Minutes for most) | Most chemotherapy drugs and Fentanyl Citrate showed >240 Minutes breakthrough detection time. |
Exceptions: Carmustine (3.3 mg/ml) - 35.0 Minutes; Thiotepa (10 mg/ml) - 64.9 Minutes. Warnings are provided for these two drugs. (See pages 2-3 and 12-13 for full list and values). | |||
ISO 10993-10 | Dermal Irritation (Rabbits) | Non irritant | Under the condition of study not an irritant (Meets criteria) |
ISO 10993-10 | Skin Sensitization (Guinea Pig) | Non sensitizer | Under the conditions of the study not a sensitizer (Meets criteria) |
ISO 10993-5:2009 | In vitro Cytotoxicity | Non cytotoxic | Under the conditions of the study cytotoxic. (Does NOT meet criteria for non-cytotoxic) |
ISO 10993-11:2017 | Acute Systemic Toxicity | Not pose systemic toxicity concern | Under the conditions of study the device extracts do not pose acute systemic toxicity concern (Meets criteria) |
ISO 10993-11:2017 / USP 41 | Material-Mediated Pyrogenicity | Not pose material mediated pyrogenicity response | Under the conditions of the study, the device did not demonstrate a material mediated pyrogenicity response (Meets criteria) |
Note on Cytotoxicity: The device itself is reported as cytotoxic under the tested conditions. This is a critical finding that does not meet a "Non cytotoxic" acceptance criterion. However, the FDA has still cleared the device. This implies that either the level of cytotoxicity observed is deemed acceptable for the intended use and risk-benefit profile of examination gloves, or mitigating factors/information were provided elsewhere (not in this summary). It's important to note this discrepancy.
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document lists various ASTM and ISO standards for testing, which define the sample sizes required for each test (e.g., AQL levels for watertightness). However, the specific quantity/sample size used for each individual test conducted by the manufacturer is not explicitly stated in this summary document beyond what's implied by the standard (e.g., AQL 1.5 for watertightness performance is a characteristic, not a sample size).
- Data Provenance: The manufacturing location of the device owner, JR Engineering & Medical Technologies (M) Sdn. Bhd., is in Malaysia (Lot 8 &10, Jalan Zurah 3 & Lot 1&3, Jalan Zurah 3A/1, Pusat Perindustrian 2, 44200 Rasa, Hulu Selangor, Selangor Darul Ehsan, Malaysia). The testing was conducted in accordance with international standards (ASTM, ISO), implying that the data originates from laboratory studies, likely conducted by third-party labs or the manufacturer's own qualified labs, but the specific country of the testing labs is not mentioned.
- Retrospective or Prospective: The testing described is prospective laboratory performance testing of the device, rather than a retrospective analysis of existing data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This product is a medical glove, not an AI or imaging device requiring expert consensus for ground truth. The "ground truth" for this device's performance is established through objective, standardized laboratory testing (e.g., ASTM D6319 for physical properties, ASTM D6978 for chemical permeation, ISO 10993 for biocompatibility). These tests rely on chemical and physical measurements, not human expert interpretation of images or clinical outcomes. Therefore, the concept of "number of experts used to establish ground truth" with qualifications like "radiologist with 10 years of experience" is not applicable to this type of device. The "experts" are the technicians and scientists performing the standardized validation tests.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. As this is not a study involving human interpretation of data where adjudication would be necessary (like in imaging diagnosis), there is no adjudication method described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a physical examination glove, not an AI or imaging diagnostic tool that would involve human readers or AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an algorithm or AI device. The tests performed are "standalone" in the sense that they assess the intrinsic material properties and barrier performance of the glove itself.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The ground truth for this device is based on standardized, objective physical, chemical, and biological measurements obtained through laboratory testing, as defined by relevant ASTM and ISO standards. This includes:
- Physical measurements (e.g., length, width, thickness, tensile strength, elongation).
- Chemical analysis (e.g., residual powder, breakthrough detection time for drugs).
- Biological testing (e.g., irritation, sensitization, cytotoxicity, systemic toxicity, pyrogenicity).
8. The sample size for the training set
Not applicable. This device is a manufactured product (glove), not an AI algorithm or model that requires a "training set" of data.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for this device.
Ask a specific question about this device
(13 days)
Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs)
Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) is a disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. This is a single-use, powder-free, non-sterile device.
Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) is a Class I patient examination gloves bearing the product codes LZA, LZC, OPJ (21CFR880.6250). They meet all the current specifications listed under the ASTM D6319-19, Standard Specification for Nitrile Examination Gloves for Medical Application and also complies with requirements for Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs as per ASTM D6978-05 (2019). They are made from Carboxylated Nitrile. These gloves are blue in color and are powder free. The product is non-sterile, textured, ambidextrous with beaded cuff and single use only. Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs) with sizes X-Small, Small, Medium, Large, X-Large and XX-Large are included in the submission.
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided FDA 510(k) summary for "Nitrile Examination Gloves Powder Free (Tested for use with Chemotherapy Drugs)":
1. A table of acceptance criteria and the reported device performance
Characteristic / Test Method | Acceptance Criteria | Reported Device Performance |
---|---|---|
Physical Dimensions (ASTM D6319-19) | ||
Length | X-Small: 220 mm min; Small: 220 mm min; Medium: 230 mm min; Large: 230 mm min; X-Large: 230 mm min; XX-Large: 230 mm min | X-Small: 270 mm; Small: 273 mm; Medium: 274 mm; Large: 276 mm; X-Large: 278 mm; XX-Large: 276 mm |
Width | X-Small: 70+/-10 mm; Small: 80+/-10 mm; Medium: 95+/-10 mm; Large: 110+/-10 mm; X-Large: 120+/-10 mm; XX-Large: 130+/-10 mm | X-Small: 72 mm; Small: 82 mm; Medium: 97 mm; Large: 103 mm; X-Large: 112 mm; XX-Large: 126 mm |
Thickness | Palm: 0.05 mm min for all sizes; Finger: 0.05 mm min for all sizes | Palm: 0.12 mm for all sizes; Finger: 0.14 mm for all sizes |
Physical Properties (ASTM D6319-19) | ||
Tensile Strength (Before Ageing) | 14 MPa min for all sizes | X-Small: 17.7 MPa; Small: 18.1 MPa; Medium: 18.3 MPa; Large: 18.4 MPa; X-Large: 18.2 MPa; XX-Large: 18.5 MPa |
Tensile Strength (After Ageing) | 14 MPa min for all sizes | X-Small: 16.8 MPa; Small: 17.3 MPa; Medium: 17.2 MPa; Large: 17.6 MPa; X-Large: 17.5 MPa; XX-Large: 17.6 MPa |
Ultimate Elongation (Before Ageing) | 500% min for all sizes | X-Small: 637%; Small: 634%; Medium: 647%; Large: 630%; X-Large: 644%; XX-Large: 644% |
Ultimate Elongation (After Ageing) | 400% min for all sizes | X-Small: 532%; Small: 539%; Medium: 542%; Large: 536%; X-Large: 529%; XX-Large: 533% |
Freedom from Holes (ASTM D5151-19) | AQL 2.5 | Gloves Passes AQL 2.5 |
Residual Powder (ASTM D6124-06) | $\leq$ 2 mg/glove | X-Small: 0.21 mg/glove; Small: 0.18 mg/glove; Medium: 0.18 mg/glove; Large: 0.19 mg/glove; X-Large: 0.21 mg/glove; XX-Large: 0.20 mg/glove |
Chemotherapy Drug Permeation (ASTM D6978-05 (2019)) | ||
Carboplatin (10mg/ml) | > 240 Minutes | > 240 Minutes |
Carmustine (3.3mg/ml) | Not specified as an acceptance criterion value, but rather a reported breakthrough time leading to a warning. No specific "pass/fail" for this drug against a threshold is listed. | 15.9 Minutes |
Cisplatin (1mg/ml) | > 240 Minutes | > 240 Minutes |
Cyclophosphamide (20mg/ml) | > 240 Minutes | > 240 Minutes |
Cytarabine HCl (100mg/ml) | > 240 Minutes | > 240 Minutes |
Dacarbazine (10mg/ml) | > 240 Minutes | > 240 Minutes |
Docetaxel (10mg/ml) | > 240 Minutes | > 240 Minutes |
Doxorubicin HCl (2mg/ml) | > 240 Minutes | > 240 Minutes |
Etoposide (20mg/ml) | > 240 Minutes | > 240 Minutes |
Fluorouracil (50mg/ml) | > 240 Minutes | > 240 Minutes |
Gemcitabine (38mg/ml) | > 240 Minutes | > 240 Minutes |
Ifosfamide (50mg/ml) | > 240 Minutes | > 240 Minutes |
Irinotecan (20mg/ml) | > 240 Minutes | > 240 Minutes |
Mechlorethamine HCl (1mg/ml) | > 240 Minutes | > 240 Minutes |
Melphalan (5mg/ml) | > 240 Minutes | > 240 Minutes |
Methotrexate (25mg/ml) | > 240 Minutes | > 240 Minutes |
Mitoxantrone (2mg/ml) | > 240 Minutes | > 240 Minutes |
Paclitaxel (6mg/ml) | > 240 Minutes | > 240 Minutes |
Thiotepa (10mg/ml) | Not specified as an acceptance criterion value, but rather a reported breakthrough time leading to a warning. No specific "pass/fail" for this drug against a threshold is listed. | 54.2 Minutes |
Biocompatibility (ISO 10993 Series) | ||
Primary Skin Irritation (ISO 10993-23) | Under the condition of study not an irritant | Under the condition of study, not an irritant |
Dermal Sensitization (ISO 10993-10) | Under the conditions of the study, not a sensitizer | Under the conditions of the study, not a sensitizer |
In Vitro Cytotoxicity (ISO 10993-5) | Under the conditions of the study, non-cytotoxic | Under the conditions of the study, non-cytotoxic |
Acute Systemic Toxicity (ISO 10993-11) | Under the conditions of study, the device extracts do not pose a systemic toxicity concern | Under the conditions of the study, the test item did not produce any adverse effect |
2. Sample size used for the test set and the data provenance
The document does not explicitly state the specific sample sizes used for each test. For many of the physical and chemical property tests (e.g., dimensions, tensile strength, freedom from holes, residual powder, chemotherapy drug permeation), the relevant ASTM standards (e.g., ASTM D6319-19, ASTM D5151-19, ASTM D6124-06, ASTM D6978-05) would specify the required statistical sampling plans, but the summary document only provides the results.
Similarly, for biocompatibility tests (ISO 10993 series), the number of animals or cell cultures used is not detailed in this summary, but the standards themselves outline the required protocols.
The data provenance is not explicitly stated in terms of country of origin of the data or whether it was retrospective or prospective. Given that these are bench and lab tests for a premarket notification, it's highly probable that the tests were conducted prospectively by the manufacturer or a contracted testing laboratory to demonstrate compliance with the referenced standards.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This information is not applicable and not provided since the studies performed are bench testing and biocompatibility testing against established international standards (ASTM and ISO). These types of tests do not typically involve human experts establishing a "ground truth" through interpretation, as would be the case for an AI diagnostic device. Instead, the "ground truth" is defined by the objective measurement parameters and criteria specified in the standard test methods themselves.
4. Adjudication method for the test set
Not applicable. As noted above, these are objective bench and lab tests against predefined specifications in standards. There is no subjective interpretation requiring an adjudication method like 2+1 or 3+1. The results are quantitative measurements or direct observations (e.g., passes/fails AQL).
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a medical glove, not an AI diagnostic device. Therefore, no MRMC study involving human readers or AI assistance was conducted or would be relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a medical glove, not an AI algorithm.
7. The type of ground truth used
The "ground truth" for the performance evaluation of these nitrile examination gloves are the acceptance criteria defined by the relevant ASTM and ISO standards. These standards provide:
- Specific measurable thresholds (e.g., minimum length, minimum tensile strength, maximum residual powder).
- Defined test methods and methodologies (e.g., how to measure breakthrough time for chemotherapy drugs, how to assess irritation or sensitization).
- Statistical sampling plans (e.g., AQL for freedom from holes).
Compliance with these pre-defined, objective criteria from the standards constitutes the "ground truth" for the device's performance.
8. The sample size for the training set
Not applicable. This is a physical device (medical glove), not an AI model. Therefore, there is no "training set."
9. How the ground truth for the training set was established
Not applicable, as there is no training set for a physical medical device.
Ask a specific question about this device
(94 days)
Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs
JR Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs is a disposable device intended for medical purpose that is worn on the examination between patient and examiner.
Additionally, the gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Medical Glove to Permeation by Chemotherapy Drugs.
The tested chemotherapy drugs and their breakthrough detection times are as follows:
Tested Chemotherapy Drug Name & Concentration | Minimum Breakthrough Detection Time |
---|---|
Carmustine (BCNU) (3.3 mg/ml) | 35.0 Minutes |
Carboplatin (10 mg/ml) | >240 Minutes |
Cisplatin (1 mg/ml) | >240 Minutes |
Cyclophosphamide (Cytoxan) (20 mg/ml) | >240 Minutes |
Dacarbazine (10.0 mg/ml) | >240 Minutes |
Doxorubicin HCl (2 mg/ml) | >240 Minutes |
Etoposide (20 mg/ml) | >240 Minutes |
Fluorouracil (50 mg/ml) | >240 Minutes |
Ifosfamide (50 mg/ml) | >240 Minutes |
Methotrexate (25 mg/ml) | >240 Minutes |
Mitomycin C (0.5 mg/ml) | >240 Minutes |
Mitoxantrone (2 mg/ml) | >240 Minutes |
Paclitaxel (6 mg/ml) | >240 Minutes |
Thiotepa (10 mg/ml) | 64.9 Minutes |
Vincristine Sulfate (1 mg/ml) | >240 Minutes |
The subject device in 510(K) notification is JR Medic blue nitrile examination gloves powder free tested for use with Chemotherapy drugs.
The subject device is a patient examination glove made from acrylonitrile-butadiene copolymer dispersion, blue color, powder free and non sterile (as per 21CFR 880.6250, class I).
The subject device meets all the current specifications listed under the ASTM Specification D 6319 -2019, Standard Specification for Nitrile Examination Gloves for Medical Application. This device also complies with requirements for standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs as per ASTM D6978- 05(2019)
I am sorry, but the provided text does not describe a study involving an AI device or algorithm, and therefore all the requested information about acceptance criteria, study design, sample sizes, ground truth, expert involvement, and MRMC studies cannot be extracted.
The document is a 510(k) premarket notification for "JR Medic Blue Nitrile Examination Powder Free Gloves tested for use with chemotherapy drugs." It details the non-clinical testing performed on these medical gloves to demonstrate their safety and effectiveness, specifically their resistance to permeation by chemotherapy drugs, in accordance with established ASTM (American Society for Testing and Materials) standards.
The document focuses on the physical, chemical, and biocompatibility properties of the gloves, not on the performance of a software algorithm or AI.
Ask a specific question about this device
Page 1 of 1